Table 1.
Author and country | Population | Key measures | Study design | Findings and evaluation |
---|---|---|---|---|
Yang et al. (2012) Republic of Korea [15] |
34 gynaecological cancer survivors (93% cervical cancer) treated with radical hysterectomy and pelvic lymph node dissection Mean age = 52.4 years |
Pelvic floor strength (MEPs); The pelvic floor questionnaire; QOL (EORTC-QLQ-C30; EORTC-QLQ-CX 24) |
RCT; intervention (4-week pelvic floor muscle training programme [PFRF]; n = 17) and usual care (Non-PFRF; n = 17) |
Completion rate = 86% Sig. improvements in the PFRF group in sexual function from T0-T1 Improvements in physical function, pain, sexual worry, sexual activity and sexual/ vaginal activity from T0 to T1 |
Donnelly et al. (2009) UK [14] |
33 sedentary gynaecological cancer survivors (stage I–III; ≥ 3 years post diagnosis), experiencing treatment-related fatigue (12% cervical cancer) Mean age = 53 years |
Fatigue (MFSI-SF; FACIT-F) QOL (FACT-G); depression (BDI-II); affect (PANAS); physical functioning (12-min walk test) |
RCT; 12-week moderate-intensity PA intervention (PA; walking; strengthening exercises; weekly consultation; 2-follow-up telephone calls; n = 16) or contact control (CC) group (n = 17) |
Recruitment rate (of those eligible) = 25% Sig. decrease in fatigue (P/I; F/U) and increase in QOL (F/U) in PA group compared to CC group Sig. difference in positive and negative affect between groups |
KEY: n, number of participants; QOL, quality of life; EORTC, European Organisation for Research and Treatment of Cancer; MEPs, motor evoked potentials; MSFI-SF, Multi-dimensional Fatigue Symptom Inventory–Short Form; FACT-G/En, the Functional Assessment of Cancer Therapy-General/endometrial cancer-specific scale; BDI-II, Beck Depression Inventory; PANAS, positive and negative effect; Schedule; RCT, randomised control trial; PA, physical activity; Sig., significant; P/I, post-intervention; F/U, follow-up; T0, baseline; T1,timepoint 1